This inventor holds 1 USPTO granted patent. Top assignees: Medisa Shinyaku Inc., Sawai Pharmaceutical Co., Ltd.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1998
Title: The Innovative Contributions of Yoshiteru Ueno
Introduction
Yoshiteru Ueno is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of infections caused by acid-fast bacteria. His innovative approach has the potential to enhance the accuracy and efficiency of diagnosing such infections.
Latest Patents
Ueno holds a patent for a method for diagnosing infections caused by acid-fast bacteria. This patent includes a reagent for the detection of an antibody against an acid-fast bacterial antigen. The reagent comprises compounds such as mycolic acids, mycolic acid salts, and esters of fatty acids. His method simplifies the procedures involved and offers much higher specificity compared to conventional reagents and methods. This advancement enables the identification of various acid-fast bacterial genera, including Mycobacterium, Nocardia, and Rhodococcus. Consequently, it allows for quicker and more accurate diagnoses, leading to timely therapeutic interventions.
Career Highlights
Throughout his career, Ueno has worked with reputable companies, including Sawai Pharmaceutical Co., Ltd. and Medisa Shinyaku Inc. His experience in these organizations has contributed to his expertise in the field of medical diagnostics and innovation.
Collaborations
Ueno has collaborated with notable colleagues such as Ikuya Yano and Shiro Oka. These partnerships have likely fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Yoshiteru Ueno's contributions to the field of medical diagnostics through his innovative patent demonstrate his commitment to improving healthcare. His work not only enhances the specificity of diagnostic methods but also facilitates timely treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile